Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACARBAZINE for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 23 adverse event reports in the FDA FAERS database where DACARBAZINE was used for Neoplasm malignant.

Most Reported Side Effects for DACARBAZINE

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 501 9.8% 50 335
Off label use 471 9.2% 120 159
Neutropenia 400 7.8% 48 163
Drug ineffective 261 5.1% 50 54
Pyrexia 245 4.8% 25 184
Neuropathy peripheral 239 4.7% 8 28
Product use in unapproved indication 219 4.3% 65 70
Disease progression 204 4.0% 33 17
Nausea 203 4.0% 23 123
Anaemia 186 3.6% 20 64
Vomiting 158 3.1% 27 105
Sepsis 156 3.1% 80 92
Diarrhoea 154 3.0% 35 104
Second primary malignancy 154 3.0% 81 35
Thrombocytopenia 153 3.0% 19 57

Other Indications for DACARBAZINE

Hodgkin's disease (3,178) Product used for unknown indication (343) Malignant melanoma (83) Lymphoma (81) Neuroblastoma (81) Chemotherapy (72) Hodgkin's disease stage iv (55) Hodgkin's disease nodular sclerosis (50) Metastatic malignant melanoma (47) Hodgkin's disease stage ii (44)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

DACARBAZINE Full Profile All Neoplasm malignant Drugs DACARBAZINE Demographics DACARBAZINE Timeline